Range Low Price High Price Comment
30 days $6.67 $9.59 Wednesday, 1st May 2024 FULC stock ended at $7.33. This is 2.81% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.18% from a day low at $7.14 to a day high of $7.51.
90 days $6.67 $13.70
52 weeks $2.63 $13.70

Historical Fulcrum Therapeutics, Inc. prices

Date Open High Low Close Volume
Mar 26, 2024 $9.46 $9.81 $9.13 $9.13 736 559
Mar 25, 2024 $9.67 $9.73 $8.85 $9.43 835 386
Mar 22, 2024 $9.76 $10.09 $9.27 $9.67 1 197 866
Mar 21, 2024 $9.86 $10.07 $9.70 $9.79 411 669
Mar 20, 2024 $9.87 $10.11 $9.67 $9.74 650 571
Mar 19, 2024 $10.04 $10.34 $9.98 $10.10 501 115
Mar 18, 2024 $11.48 $11.48 $9.99 $10.12 812 361
Mar 15, 2024 $11.24 $11.46 $11.13 $11.36 411 961
Mar 14, 2024 $11.34 $11.80 $11.10 $11.18 444 869
Mar 13, 2024 $11.37 $12.40 $11.20 $11.36 1 168 525
Mar 12, 2024 $11.31 $11.38 $10.56 $10.91 481 552
Mar 11, 2024 $10.97 $11.68 $10.80 $11.28 422 354
Mar 08, 2024 $11.48 $11.90 $10.95 $11.08 604 493
Mar 07, 2024 $12.00 $12.34 $10.84 $11.31 1 442 297
Mar 06, 2024 $12.48 $13.70 $11.97 $12.00 1 629 710
Mar 05, 2024 $10.99 $11.40 $10.86 $10.96 533 747
Mar 04, 2024 $11.23 $11.51 $10.96 $11.33 948 746
Mar 01, 2024 $10.46 $11.22 $10.28 $10.99 1 253 367
Feb 29, 2024 $10.27 $10.65 $10.19 $10.21 1 057 536
Feb 28, 2024 $10.27 $11.03 $9.98 $10.32 1 152 116
Feb 27, 2024 $10.00 $10.50 $9.40 $10.18 1 500 155
Feb 26, 2024 $9.60 $9.97 $9.56 $9.73 493 280
Feb 23, 2024 $9.59 $9.76 $9.43 $9.60 302 898
Feb 22, 2024 $9.61 $9.86 $9.51 $9.55 234 767
Feb 21, 2024 $9.38 $9.64 $9.20 $9.55 290 542
Click to get the best stock tips daily for free!

About Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics. Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell di... FULC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT